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The familial tendency of dia-
betes has been recognized for cen-
turies. The genetic studies of Pincus 
and White (1933) , Steinberg and 
Wilder (1952), Post (1962), and 
others seem to indicate that dia-
betes is transmitted as a simple 
autosomal recessive trait. If this is 
so, it is obvious that the tendency 
to diabetes must be established at 
the moment of conception. What 
does this tendency to diabetes con-
sist of, and what determines when 
the disease we have called "dia-
betes" will appear? What is the 
status of the predisposed individual 
prior to the onset of overt dia-
betes? 
It has long been known that 
large babies are often born to 
mothers later destined to become 
diabetic. This and the observation 
that transient diabetes during preg-
nancy or other stress is often the 
forerunner of later overt diabetes 
led Jackson (1960), Conn and 
Fajans (1961), and others to re-
gard this period before the develop-
ment of obvious diabetes as an im-
portant one, a period of active 
dynamic changes which culminate 
in the appearance of clinical dia-
betes. Jackson, and Conn and Fa-
jans have called this period "pre-
diabetes. " Others prefer the term, 
"diabetes premellitus." 
We might define diabetes as a 
genetically determined metabolic 
disease, the predisposition to which 
is established at conception. It may 
ultimately progress to the stage of 
clinical diabetes with insulin insuf-
ficiency and the accompanying 
manifestations of hyperglycemia, 
glycosuria, and abnormal metabo-
lism of protein and fat. 
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ST AGES OF DIABETES 
The life history of a diabetic pa-
tient may be regarded as consisting 
of three stages: (I) prediabetes, 
(II) asymptomatic or chemical dia-
betes, and (III) overt or sympto-
matic diabetes. Asymptomatic or 
chemical diabetes is sometimes 
further divided into diabetes pres-
ent only with stress, and diabetes 
present without stress (Table 1). 
In general, the diabetic patient 
appears to progress through one 
stage to the next, although in some 
patients, stage II is either very brief 
or unrecognized, and many dia-
betics may remain asymptomatic 
and never reach stage III. Diabetes 
appearing early in life is more 
likely to be severe, and diabetes de-
veloping late in life generally is 
mild and often asymptomatic. Some 
factors that can alter the natural 
course of diabetes are illustrated in 
Figures 1 and 2. 
VASCULAR DISEASE AND 
BIOCHEMICAL CHANGES IN 
PREDIABETIC STATE 
It would appear that the key to 
better understanding of the patho-
physiology of diabetes might be 
found in the events occurring in the 
prediabetic period. The first prob-
lem lies in knowing how to recog-
nize the prediabetic patient, since, 
by definition, all tests of carbohy-
drate metabolism are normal in this 
state. Camerini-Diivalos ( 1965a and 
b), Rees and their colleagues (1964) 
.have attacked the problem by study-
ing a group of children who were 
either the identical twins of dia-
betic patients or the children of two 
diabetic parents. Such children 
should all be genetically predia-
betic, although all need not develop 
diabetes. These authors have mar-
shalled impressive evidence both of 
beginning vascular disease of the 
diabetic type, and of certain bio-
chemical abnormalities preceding 
the development of chemically de-
tectable diabetes. 
Vascular abnormalities found in 
prediabetes include: (a) abnormal 
finger pulse waves (Camerini-
Diivalos, 1965a), (b) venular dila-
tation in the bulbar conjunctiva 
with increased venule : arteriole di-
ameter ratio (Camerini-Diivalos et 
al., 1964), (c) thickened basement 
membrane of capillaries on gingival 
biopsy (Camerini-Diivalos, 1965b), 
(d) on ear lobe biopsy (Camerini-
Diivalos et al., 1964), and (e) in 
the glomerular capillaries on renal 
biopsy ( Camerini-Diivalos, 1965a). 
In addition it seems likely that 
some fetal abnormalities in babies 
of prediabetic mothers may result 
from vascular disturbances in the 
placenta. 
Chemical changes reported in 
prediabetes include the following : 
(a) Although the glucose tolerance 
test of the prediabetic is within nor-
mal limits, the mean blood sugar of 
all prediabetics is significantly 
higher than that of non-prediabetic 
controls at 1, 1 V2, 2 and 3 hours 
after glucose. (b) In prediabetics 
the fasting serum free fatty acids 
are increased, and their fall after 
glucose is delayed. ( c) Serum sialic 
acid is increased in prediabetes. 
( d) Serum insulin-like-activity 
(ILA) is increased fasting and after 
glucose (Camerini-Diivalos, 1965a). 
( e) Synalbumin insulin antagonist 
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of Vallance-Owen is increased 
(Vallance-Owen and Ashton, 1963). 
(f) "Bound" insulin of Antoniades 
is increased (Camerini-Davalos, 
1965a). (g) Prediabetics show an 
increased rise in blood growth hor-
mone three hours after glucose, fol-
lowing the initial supression of 
growth hormone levels by the glu-
cose (Unger, 1965). 
Many of these biochemical 
changes are slight and many need 
confirmation. The significance of 
increases in ILA or in "bound" in-
sulin is in dispute. Nevertheless it 
does appear that there are biochem-
ical abnormalities during predia-
betes. Among these observations 
the most significant would seem to 
be the finding of increased amounts 
of insulin in the blood, even by im-
munoassay when measured 1 hour 
after glucose, not only in predia-
betics, but early in the course of 
juvenile diabetes, and in most 
maturity-onset diabetics. The find-
ing of a high insulin level at a time 
when blood sugar is high challenges 
our earlier concept of diabetes as a 
manifestation of simple insulin in-
sufficiency. There must be a reason 
for the apparent ineffectiveness of 
insulin. This question is at the heart 
of much of the investigation in dia-
betes today. Some of the possible 
causes for insulin ineffectiveness 
that have been proposed are listed 
in Table 2. 
THE PRIMARY METABOLIC 
DEFECT IN DIABETES 
Whatever mechanism is ulti-
mately found to be responsible for 
insulin antagonism, current think-
ing strongly favors the concept that 
the primary event in diabetes is not 
pancreatic failure, but extrapancre-
atic antagonism to insulin or inacti-
vation of insulin of some sort. As 
available active insulin diminishes, 
some form of feedback mechanism, 
possibly a transitory rise in blood 
glucose, causes the pancreas to re-
lease more insulin until a new 
equilibrium is reached. During the 
stage of prediabetes, this compensa-
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TABLE 1 
Stages in Life History of a Diabetic 
From conception to first evidence of 
I. Prediabetes impaired insulin reserve. No demon-
strabl e abnormality in carbohydrate 
metabolism. 
(a) With stress only: 
Blood sugar (BS) elevated only with 
stress, such as i.nfection or pregnancy. 
II. Asymptomatic or Glucose tolerance test (GTT) normal. 
Chemical Diabetes Cortisone GTT abnormal. 
(b) Present without stress: 
Postprandial BS elevated. Fasting 
BS normal or slightly elevated. Little 
or no g lycosuria. GTT abnormal. 
Ill. Symptomatic or Persistent hyperglycemia and glycosuria. 
Overt Diabetes Po lyuria, thirst, etc. G TT not necessary. 
tory process is able to maintain 
normal or nearly normal carbohy-
drate metabolism. If the antagonism 
to insulin continues, the pancreas 
may be driven to the point of fail-
ure. Such islet cell failure may be 
first manifest by inability to release 
insulin promptly in response to a 
rise in blood glucose. The process 
may be at first reversible to some 
extent, but later becomes irreversi-
ble with more or less complete fail-
ure of insulin secretion. This seems 
to be the case with many juvenile 
diabetics where early remission oc-
curs after institution of treatment, 
only to be followed in a few months 
by total and permanent pancreatic 
failure. In the maturity-onset dia-
betic, the antagonism to insulin is 
less severe; pancreatic failure de-
velops only late in life and seldom 
becomes complete. In many such 
patients the use of sulfonylurea 
drugs improves the release of insu-
lin by the ft-cells to a degree ade-
quate to maintain carbohydrate 
homeostasis. 
VASCULAR COMPLICATIONS 
OF DIABETES 
The vascular disease of diabetes 
is chiefly a microangiopathy, i.e., a 
degenerative change in capillaries, 
venules, and arterioles throughout 
the body that eventually produces 
such pathologic lesions as retinop-
athy, glomerulosclerosis, and possi-
bly neuropathy. These complica-
tions were formerly thought to 
result from years of deranged me-
tabolism. The discovery of incipient 
microangiopathy in various sites in 
prediabetes and in the early stages 
of chemical diabetes casts doubt on 
the view that these changes result 
solely from the metabolic abnor-
mality produced by insulin defi-
ciency and supports the view that 
the metabolic disturbance and the 
vascular disease may be independ-
ent facets of the fundamental 
genetic disease. On the other hand, 
there is a sizeable body of clinical 
opinion that the progression of vas-
cular disease is more severe in 
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Fig. 1-The course of diabetes with age is indicated as a line sloping upward as 
the disease becomes more severe. Prediabetes is indicated as a clear zone, and 
diabetes is indicated by stippling, which is heavier toward the top as the disease 
becomes more severe. The juvenile diabetic progresses rapidly through predia-
betes and asymptomatic diabetes to the abrupt onset of overt diabetes, usually 
severe and with obvious symptoms. The maturity-onset diabetic follows a line 
with a smaller slope and reaches the stage of chemical diabetes in middle life. 
Other predisposed individuals may never develop diabetes at all. Along this 
course or life-curve, events producing stress such as pregnancy or infection can 
make diabetes worse and can bring out chemical or even symptomatic diabetes 
in a prediabetic individual. When stress is removed, diabetes may return to its 
previous undetectable state, or at least to a subclinical or asymptomatic state. 
OVERT OR 
SYMPTOMATIC 
DIABETES 
CHEMICAL OR 
ASYMPTOMATIC 
DIABETES 
PRE DIABETES 
10 20 30 40 50 60 70 80 
AGE 
Fig. 2-Effect of obesity and weight reduction on the course of diabetes. Obesity 
often converts prediabetes or mild asymptomatic diabetes to overt diabetes. With 
weight reduction alone, the diabetes may disappear entirely or revert to a mild 
asymptomatic state. 
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those patients with the greatest 
metabolic abnormality, although 
Knowles ( 1964), reviewing all the 
literature, did not believe the ques-
tion could be answered on the pres-
ent evidence. The appearance of 
retinitis and glomerulosclerosis in 
patients with diabetes resulting from 
hemochromatosis (Becker and Mil-
ler, 1960) or pancreatitis, and the 
observation that similar lesions de-
velop in dogs made diabetic by al-
loxan or growth hormone (Blood-
worth, 1965), bring us back to the 
role of insulin deficiency and al-
tered metabolism in the genesis of 
the vascular lesion. The fact that 
the glucose tolerance tests of pre-
diabetics, while normal, show sig-
nificantly higher blood sugar levels 
after glucose than in non-predia-
betics suggests that there may al-
ready be some deficiency of effec-
tive insulin, which could be a factor 
in the appearance of vascular ab-
normalities at this stage. The final 
answers to these questions are un-
known. In the meantime, our posi-
tion should admit the possibility of 
both genetic and metabolic factors. 
It would seem reasonable to use the 
measures of treatment available to 
keep the chemistry of the diabetic 
as near normal as possible, while 
continuing the search for genetic or 
other factors that may be involved 
in the vascular degenerative process. 
TABLE 2 
Possible Causes of Insul in Ineffectiveness 
Considered, but ruled out: 
I.Abnormal insulin 
2 . lncreosed insulin destruction 
Currently suggested: 
I. Binding or inactivation of insulin: 
a. 11free 11 and 11 bound" (Antoniades, 
1964) 
b. 11 Typical 11 and 11atypical 11 (Samoan, 
1963) 
2. Synalbvmin insul in antagonist 
(Vallance-Owen , 1964) 
3. FFA inhibition of insulin action 
(Randle, 1963) 
4. Growth hormone 
5. Auto-immune process 
6. Tissue resistance to insulin 
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